HomeMy WebLinkAboutResolution - 2024-R0305 - Amendment No. 4, Contract HHS000812700012, DSHS - 07/09/2024Resolution No. 2024-RO305
Item No. 6.5.1
July 9, 2024
RESOLUTION
BE IT RESOLVED BY THE CITY COUNCIL OF THE CITY OF LUBBOCK:
THAT the Mayor of the City of Lubbock is hereby authorized and directed to execute
for and on behalf of the City of Lubbock, Amendment No. 4 to the Department of State Health
Services (DSHS) Contract No. HHS000812700012, for SARS-CoV-2 epidemiology,
surveillance, and enhanced laboratory activities, by and between the City of Lubbock and the
State of Texas, acting by and through DSHS, and all related documents. Said Amendment is
attached hereto and incorporated in this resolution as if fully set forth herein and shall be
included in the minutes of the City Council.
Passed by the City Council on July 9, 2024 __ _ _ _—
IaM
/t/ MARK CBRAYER, MAYOR
A EST: v
Courtney Paz, City Secretary
APPROVED AS TO CONTENT:
— e - � 0, 4, - r—, �:: � 2
Bill Ho rton, Depu nager
APPROVED AS TO FORM:
achael I:oster, Xs9siant City Attorney
RES.DSHS Contract No. 14E4S000812700012 Amendment NoA
6.18.24
DocuSign Envelope ID: A25E5CEA-FD9A4EFF-691E-AC517ABAFACD
Resolution No. 2024-RO305
DEPARTMENT OF STATE HEALTH SERVICES
CONTRACT No. HHS000812700012
AMENDMENT No. 4
The DEPARTMENT OF STATE HEALTH SERVICES ("SYSTEM AGENCY" or "DSHS") and CITY OF
LUBBOCK ("GRANTEE"), each a "Party" and collectively referred to as the "Parties" to that certain
grant contract for SARS-CoV-2 epidemiology, surveillance, and enhanced laboratory activities
effective August 17, 2020, and denominated DSHS Contract No. HHS000812700012 ("Contract"),
as amended, now desire to further amend the Contract.
WHEREAS, the Parties desire to revise the Statement of Work; and
WHEREAS, the Parties desire to revise the Budget to add additional funding for SARS-CoV-2
outbreak response activities.
Now, THEREFORE, the Parties amend and modify the Contract as follows:
1. SECTION IV, BUDGET, of the Contract is hereby amended to add $145,226.00 to the
Contract for the period beginning with the effective date of this Amendment No. 4 and
ending July 31, 2026, for SARS-CoV-2 outbreak response activities. The total amount of
this Contract will not exceed $493,769.00.
2. ATTACHMENT A-1, REVISED STATEMENT OF WORK, is deleted in its entirety and replaced
with ATTACHMENT A-4, REVISED STATEMENT OF WORK, which is attached to this
Amendment and incorporated as part of the Contract for all purposes.
3. ATTACHMENT A-3, REVISED SUPPLEMENTAL STATEMENT OF WORK, is deleted in its
entirety.
4. ATTACHMENT B-2, REVISED BUDGET, is deleted in its entirety and replaced with
ATTACHMENT B-3, REVISED BUDGET, which is attached to this Amendment and
incorporated as part of the Contract for all purposes.
All expenditures under the Contract will be in accordance with ATTACHMENT B-3, REVISED
BUDGET.
5. ATTACHMENT A-4, REVISED STATEMENT OF WORK is attached to this Amendment No. 4
and incorporated as part of the Contract for all purposes.
6. ATTACHMENT B-3, REVISED BUDGET, is attached to this Amendment No. 4 and
incorporated as part of the Contract for all purposes.
7. This Amendment No. 4 shall be effective as of the date last signed below.
8. Except as amended and modified by this Amendment No. 4, all terms and conditions of the
Contract, as amended, shall remain in full force and effect.
DSHS Contract No. HHS000812700012
Amendment No. 4
Page 1 of 3
DocuSign Envelope ID: A25E5CEA-FD9A-4EFF-89IE-AC517ABAFACD
9. Any further revisions to the Contract shall be by written agreement of the Parties.
10. Each Party represents and warrants that the person executing this Amendment on its behalf
has full power and authority to enter into this Amendment.
SIGNATURE PAGE FOLLOWS
DSHS Contract No. HHS000812700012
Amendment No. 4
Page 2 of 3
DocuSign Envelope ID: A25E5CEA-FD9A-4EFF-B91 E-AC517ABAFACD
SIGNATURE PAGE FOR AMENDMENT No. 4
DSHS CONTRACT No. HHS000812700012
SYSTEM AGENCY
L
By:
Name: Varun Shetty
Title: Chief State Epidemiologist
Date of Signature: June 25, 2024
GRANTEE
L��
ccuSignedby�:
By: V - \
Name: Mark McBrayer
Title: Mayor
Date of Signature: June 25, 2024
DSHS Contract No. HHS000812700012
Amendment No. 4
Page 3 of 3
DocuSign Envelope ID: A25E5CEA-FD9A-4EFF-B9IE-AC517ABAFACD
ATTACHMENT A-4
REVISED STATEMENT OF WORK
I. GRANTEE RESPONSIBILITIES
Grantee will perform activities as submitted in their DSHS approved budgets for this
specific funding Contract period. COVID-funded laboratory, surveillance, epidemiology,
and informatics personnel may work on other respiratory pathogens and syndromes more
broadly, in addition to SARS-CoV-2 and COVID-19, as long as COVID-19 testing or
surveillance is included in the effort. In this Statement of Work where COVID-19 is
referenced, it will now include other respiratory pathogens and syndromes. All activities
must be listed below to be approved for this funding and any additional activities not listed
in the approved budget must be submitted for DSHS consideration and approval. The
activities for this Contract funding period are as follows:
A. Enhance Laboratory, Surveillance, Informatics and other Workforce Capacity,
including:
Train and hire staff to improve laboratory workforce ability to address issues
around laboratory safety, quality management, inventory management, specimen
management, diagnostic and surveillance testing and reporting results.
2. Build expertise for healthcare and community outbreak response and infection
prevention and control (IPC) among local health departments.
3. Train and hire staff to improve the capacities of the epidemiology and informatics
workforce to effectively conduct surveillance and response of COVID-19 and
other emerging infections and conditions of public health significance. This should
include staff who can address unique cultural needs of those at higher risk for
COVID-19. Grantee may not incur COVID-19 contact tracing or contact tracing
call center expenditures after 8/31/2021.
4. Build expertise to support management of the COVID-19-related activities within
the jurisdiction and integrate into the broader Epidemiology and Laboratory
Capacity (ELC) portfolio of activities (e.g., additional leadership, program and
project managers, budget staff, etc.).
5. Increase capacity for timely data management, analysis, and reporting for COVID-
19 and other emerging coronavirus and other infections and conditions of public
health significance.
B. Strengthen Laboratory Testing
1. Establish or expand capacity to test for SARS-CoV-2/COVID-19 quickly,
accurately and safely and build infectious disease preparedness for future novel
DSHS Contract No. HHS001315700012 Page 1 of 10
Attachment A-4
DocuSign Envelope ID: A25E5CEA-FD9A-4EFF-691 E-AC517ABAFACD
coronavirus and other events involving other pathogens with potential for broad
community spread.
a. Develop systems to improve speed and efficiency of specimen submission to
clinical and reference laboratories.
b. Strengthen ability to rapidly respond to testing (e.g., nucleic acid amplification
test [NAAT], antigen, etc.) as necessary to ensure that optimal utilization of
existing and new testing platforms can be supported to help meet increases in
testing demand in a timely manner. Laboratory Response Networks (LRNs)
and Local Health Departments (LHDs) with laboratories are strongly
encouraged to diversify their testing platforms to enable them to pivot
depending on reagent and supply availabilities.
c. Perform serology testing with an FDA Emergency Use Authorization (EUA)
authorized serological assay as appropriate to respond to emerging pandemics
in order to conduct surveillance for past infection and monitor community
exposure.
d. Build local capacity for testing of SARS-CoV-2/COVID-19 including within
high -risk settings or in vulnerable populations that reside in their communities.
e. Apply laboratory safety methods to ensure worker safety when managing and
testing samples that may contain SARS-CoV-2/COVID-19.
f. Laboratories and LRNs are encouraged to implement new technologies to meet
local needs.
g. Augment or add specificity to existing laboratory response plans for future
coronavirus and other outbreak responses caused by an infectious disease.
Provider must be able to establish a plan to maintain the activity when the
funds are no longer available. This is an optional activity.
2. Enhance laboratory testing capacity for SARS-CoV-2/COVID-19 by ensuring
public/private laboratory testing providers have access to biosafety resources for
SARS-CoV-2 specimen collection and/or testing.
C. Advance Electronic Data Exchange at Public Health Labs
1. Enhance and expand laboratory information infrastructure, to improve
jurisdictional visibility on laboratory data (tests performed) from all testing sites
and enable faster and more complete data exchange and reporting with DSHS.
a. Employ a well -functioning Laboratory Information Management System
(LIMS) to support efficient data flows within the Public Health Laboratory
(PHL) and its partners. This includes expanding existing capacity of the
current LIMS to improve data exchange and increase data flows through LIMS
maintenance, new configurations/modules, and enhancements. Implement
new/replacement LIMS where needed.
Note: If implementing new or replacement systems, develop an
implementation plan, including appropriate milestones and timeline to
completion. Implementation plans will be reviewed and approved for
consistency with the activities set forth by DSHS prior to start of
implementation. Completion of the implementation plan is DSHS
verifying that the submitted electronic laboratory reporting (ELR) feeds
DSHS Contract No. HHS001315700012 Page 2 of 10
Attachment A-4
DocuSign Envelope ID: A25E5CEA-FD9A-4EFF-B91 E-AC517ABAFACD
have been successfully processed in National Electronic Disease
Surveillance System (NEDSS).
b. Ensure ability to administer LIMS. Ensure the ability to configure all tests that
are in LIMS, including new tests, EUAs, etc., in a timely manner. Ensure
expanding needs for administration and management of LIMS are covered
through dedicated staff.
c. Interface diagnostic equipment to directly report laboratory results into LIMS.
D. Improve Surveillance and Reporting of Electronic Health Data
1. Establish complete, up-to-date, timely reporting to DSHS of outbreaks and
unusual expression of disease (e.g., multi -system inflammatory syndrome, acute
flaccid myelitis, etc.) due to COVID-19 and other emerging infections which
impact conditions of public health significance by:
a. Establishing or enhancing community -based surveillance, including
surveillance of vulnerable populations, individuals without severe illness,
those with recent travel to high -risk locations, or who are contacts to known
cases; and
b. Monitoring changes to activity trends (weekly, possibly daily) of COVID-19
and other conditions of public health significance at the county or Zip code
level to inform community mitigation strategies.
2. Establish additional and ongoing surveillance methods (e.g., sentinel surveillance)
for COVID-19 and other conditions of public health significance.
At the health department, enhance capacity to work with testing facilities to
onboard and improve ELR, including to receive data from new or non-traditional
testing settings. Use alternative data flows (e.g., reporting portals) and file formats
(e.g., CSV or XLS) to help automate where appropriate.
4. Improve understanding of capacity, resources, and patient impact at healthcare
facilities through electronic reporting.
a. Expand reporting facility capacity, resources, and patient impact information,
such as patients admitted and hospitalized, in an electronic, machine-readable,
as well as human -readable, visual and tabular manner, to achieve 100%
coverage in jurisdiction and include daily data from all acute care, long-term
care, and ambulatory care settings. Use this data to monitor facilities with
confirmed cases of SARS-CoV-2/COVID-19 infection or with COVID-like
illness among staff or residents and facilities at high risk of acquiring SARS-
CoV-2/COVID-19 cases and COVID-like illness among staff or residents.
b. Increase Admit, Discharge, Transfer (ADT) messaging and use to achieve
comprehensive surveillance of emergency room visits, hospital admissions,
facility and department transfers, and discharges to provide an early warning
signal, to monitor the impact on hospitals, and to understand the growth of
serious cases requiring admission.
DSHS Contract No. HHS001315700012 Page 3 of 10
Attachment A-4
DocuSign Envelope ID: A25E5CEA-FD9A-4EFF-B91 E-AC517ABAFACD
c. Track and send Emergency Department and outpatient visits for coronavirus
(COVID)-like illness, as well as other illnesses, to Texas Syndromic
Surveillance System (TxS2).
5. Establish or improve systems to ensure complete, accurate and timely data
transmission that allows for automated transmission of data to DSHS in a machine-
readable format.
Note: Use of an existing DSHS system is preferred. If implementing new
or replacement systems, develop an implementation plan, including the
process for automatic transmission of data to DSHS in a machine-readable
format, appropriate milestones and timeline to completion.
Implementation plans will be reviewed and approved for consistency with
the activities set forth by DSHS prior to start of implementation.
a. In the event of a COVID-19-associated outbreak, a local health department
should notify DSHS of the outbreak as soon as possible, by calling 512-776-
7676 or emailing EAIDU-Coronavirus(a-dshs.texas. gov.
b. In the event of a COVID-19-associated outbreak, a DSHS Respiratory
Outbreak Form along with a line listing of cases, if possible, should be
completed and submitted to EAIDU within seven days of outbreak resolution
via EAIDU-Coronavirus(a),dshs.texas.gov or by fax at 512-776-7616.
c. Establish these systems in such a manner that they may be used on an ongoing
basis for surveillance of, and reporting on, routine and other threats to the
public health and conditions of public health significance.
E. Use Laboratory Data to Enhance Investigation, Response and Prevention
Use laboratory data to initiate and conduct outbreak and/or unusual expression of
disease investigation and public health follow-up activities and implement
containment measures.
a. Conduct necessary outbreak investigation and public health follow-up
activities. Activities may include traditional case investigation for cases
associated with an outbreak and public health follow-up activities and/or
proximity/location-based methods, as well as methods adapted for healthcare
facilities, employers, elementary and secondary schools, childcare facilities,
institutions of higher education or in other settings. Data must be entered into
the DSHS data system in accordance with DSHS published guidance. Grantee
may not incur COVID-19 contact tracing or contact tracing call center
expenditures beyond 8/31/2021.
b. Utilize tools (e.g., geographic information systems and methods) that assist in
the rapid mapping and tracking of disease cases for timely and effective
epidemic monitoring and response, incorporating laboratory testing results and
other data sources.
c. Assist in identifying facilities that are not submitting data through ELR.
Provide these facilities with information on the ELR onboarding process and
the appropriate contact information of DSHS team who can onboard the
DSHS Contract No. HHS001315700012 Page 4 of 10
Attachment A-4
DocuSign Envelope ID: A25E5CEA-FD9A-4EFF-B91E-AC517ABAFACD
facility to have their data be reported electronically and no longer sent by fax.
Also provide the names of these facilities to the DSHS team.
2. Identify cases associated with an outbreak, and exposure to COVID-19 in high -
risk settings or within populations at increased risk of severe illness or death to
target mitigation strategies and referral for therapies (for example, monoclonal
antibodies) to prevent hospitalization.
a. Assess and monitor infections in healthcare workers across the healthcare
spectrum.
b. Monitor cases associated with an outbreak, and exposure to COVID-19 to
identify need for targeted mitigation strategies to isolate and prevent further
spread within high -risk healthcare facilities (e.g., hospitals, dialysis clinics,
cancer clinics, nursing homes, other long-term care facilities, etc.).
c. Monitor cases associated with an outbreak, and exposure to COVID-19 to
identify need for targeted mitigation strategies to isolate and prevent further
spread within high -risk occupational settings (e.g., meat processing facilities)
and congregate living settings (e.g., correctional facilities, prisons, youth
homes, shelters).
d. Work with DSHS to build capacity for reporting, rapid containment and
prevention of SARS-CoV-2/COVID-19 within high -risk settings or in
vulnerable populations that reside in their communities.
e. Jurisdictions should ensure systems are in place to link test results to relevant
public health strategies, including prevention and treatment.
Note: Utilization of an existing DSHS system is preferred. If
implementing new or replacement systems, develop an implementation
plan, including the process for automatic transmission of data to DSHS in
a machine-readable format, appropriate milestones and timeline to
completion. Implementation plans will be reviewed and approved for
consistency with the activities set forth by DSHS prior to start of
implementation.
Implement prevention strategies in high -risk settings or within vulnerable populations
(including tribal nations as appropriate),
Note: These additional resources are intended to be directed toward testing,
outbreak investigation and public health follow-up activities, surveillance,
containment, and mitigation, including support for workforce, epidemiology, use
by employers, elementary and secondary schools, childcare facilities, institutions
of higher education, long-term care facilities, or in other settings, scale -up of
testing by public health, academic, commercial, and hospital laboratories, and
community -based testing sites, mobile testing units, healthcare facilities, and other
entities engaged in COVID-19 testing, and other related activities related to
COVID-19 testing, case investigation and public health follow-up activities,
surveillance, containment, and mitigation which may include interstate compacts
or other mutual aid agreements for such purposes.
DSHS Contract No. HHS001315700012 Page 5 of 10
Attachment A-4
DocuSign Envelope ID: A25E5CEA-FD9A-4EFF-B9IE-AC517ABAFACD
a. Build capacity for infection prevention and control in long-term care facilities
(LTCFs) (e.g., at least one Infection Preventionist [IP] for every facility) and
outpatient settings.
i. Build capacity for LTCFs to safely care for infected and exposed
residents of LTCFs and other congregate settings.
ii. Assist with enrollment of all LTCFs into CDC's National Healthcare
Safety Network (NHSN) at hgps://www.cdc.gov/nhsn/Itc/enroll.html.
b. Build capacity for infection prevention and control in elementary and
secondary schools, childcare facilities, and/or institutions of higher education.
c. Increase Infection Prevention and Control (IPC) assessment capacity on site
using tele-ICAR.
d. Perform preparedness assessment to ensure interventions are in place to protect
high -risk populations.
e. Coordinate as appropriate with federally funded entities responsible for
providing health services to higher -risk populations (e.g., tribal nations and
federally qualified health centers).
F. Work with healthcare system to manage and monitor system capacity.
1. Assess and monitor the number and availability of critical care staff, necessary
personal protective equipment (PPE) and potentially life-saving medical
equipment, as well as access to testing services.
2. Leverage NHSN data to monitor healthcare worker staffing, Patient Impact,
Hospital Capacity, and healthcare supplies (PPE, PAPRs, ventilators, etc.).
Grantee will request access to the NHSN database within thirty (30) days of the
execution of this Contract or within thirty (30) days of hire for the position
completing the data entry. Upon access approval, Grantee will review available
NHSN data (at least monthly) to assess gaps in the healthcare system.
G. Improve understanding of jurisdictional communities with respect to COVID-19 risk.
Grantee must build an understanding of population density and high -risk population
density (i.e., population of >65 yrs., proportion of population with underlying
conditions, households with limited English fluency, healthcare -seeking behavior,
populations without insurance and those below poverty level).
H. Submit a quarterly report on the report template to be provided by DSHS. Quarterly
reports are due on or before the 15t' of the month following the end of the quarter.
Each report must contain a summary of activities that occurred during the preceding
quarter for each activity listed above in Section I, Subsections A through G. Submit
quarterly reports by electronic mail to COVID.Contracts(iWshs. texas. gov. The email
"Subject Line" and the name of the attached file for all reports should be clearly
identified with the Grantee's Name, Contract Number, IDCU/COVID and the quarter
the report covers.
I. May use funds to pay pre -award costs which date back to January 20, 2020, that are
directly related to the COVID-19 outbreak response. All pre -award costs must be
approved in writing by DSHS.
DSHS Contract No. HHS001315700012 Page 6 of 10
Attachment A-4
DocuSign Envelope ID: A25E5CEA-FD9A-4EFF-691E-AC517ABAFACD
J. Not use funds for research, clinical care, fundraising activities, construction or major
renovations, to supplant existing state or federal funds for activities, or funding an
award to another party or provider who is ineligible. In addition, funds are not used
to advertise or to promote COVID-19 vaccinations. Other than normal and recognized
executive -legislative relationships, no funds may be used for:
1. Publicity or propaganda purposes, for the preparation, distribution, or use of any
material designed to support or defeat the enactment of legislation before any
legislative body;
2. The salary or expenses of any grant or contract recipient, or agent acting for such
recipient, related to any activity designed to influence the enactment of legislation,
appropriations, regulation, administrative act or Executive order proposed or
pending before any legislative body;
3. New incentive requests, new requests to purchase vehicles, furniture, and new
requests for construction will no longer be supported. The allowance of these
purchases was uniquely given during the pandemic, but they are not allowed under
routine operations; and
4. Grantee shall ensure funds are not used to advertise or to promote COVID-19
vaccinations.
K. Controlled Assets include firearms, regardless of the acquisition cost, and the
following assets with an acquisition cost of $500 or more, but less than $5,000:
desktop and laptop computers (including notebooks, tablets and similar devices), non -
portable printers and copiers, emergency management equipment, communication
devices and systems, medical and laboratory equipment, and media equipment.
Controlled Assets are considered Supplies.
L. Grantee shall maintain an inventory of equipment, supplies defined as Controlled
Assets, and real property. Grantee shall submit an annual cumulative report on DSHS
Grantee's Property Inventory Report to the DSHS Contract Representative and
FSOequipAdshs. texas. gov by email not later than October 15 of each year.
M. DSHS funds must not be used to purchase buildings or real property without prior
written approval from DSHS. Any costs related to the initial acquisition of the
buildings or real property are not allowable without written pre -approval.
N. At the expiration or termination of this Contact for any reason, title to any remaining
equipment and supplies purchased with funds under this Contract reverts to DSHS.
Title may be transferred to any other party designated by DSHS. DSHS may, at its
option and to the extent allowed by law, transfer the reversionary interest to such
property to Grantee.
O. DSHS-approved budget may be revised by Grantee in accordance with the following
requirements:
DSHS Contract No. HHS001315700012 Page 7 of 10
Attachment A-4
DocuSign Envelope ID: A25E5CEA-FD9A-4EFF-B9IE-AC517ABAFACD
1. For any transfer between budget categories, Grantee shall provide notification of
transfer between budget categories by submission of a revised Categorical Budget
Form to the DSHS Contract Representative, highlighting the areas affected by the
budget transfer and written justification for the transfer request. After DSHS
review, the designated DSHS Contract Representative will provide notification of
acceptance or rejection to Grantee by email.
2. For transfer of funds between direct budget categories, other than the `Equipment'
and `Indirect Cost' categories, for less than or equal to a cumulative twenty-five
(25) percent of the total value of the respective Contract budget period, Grantee
shall submit timely written notification to DSHS Contract Representative using
the Revised Budget Form and request DSHS approval. If approved, DSHS
Contract Representative will provide notification of acceptance to Grantee by
email, upon receipt of which, the revised budget will be incorporated into the
Contract.
3. For transfer of funds between direct budget categories, other than the `Equipment'
and `Indirect Cost' categories, that cumulatively exceeds twenty-five (25) percent
of the total value of the respective Contract budget period, Grantee shall submit
timely written notification to DSHS Contract Representative using the Revised
Budget Form and request DSHS approval. If the revision is approved, the budget
revision is not authorized, and the funds cannot be utilized, until an amendment is
executed by the Parties.
4. Any transfer between budget categories that includes `Equipment' and/or` Indirect
Cost' categories must be incorporated by amendment. Grantee shall submit timely
written notification to DSHS Contract Representative using the Revised Budget
Form and request DSHS approval. If the revision is approved, the budget revision
is not authorized, and the funds cannot be utilized, until an amendment is executed
by the Parties.
II. PERFORMANCE MEASURES
The System Agency will monitor the Grantee's performance of the requirements in
Attachment A-4 and compliance with the Contract's terms and conditions.
Ill. INVOICE AND PAYMENT
A. Grantee shall submit to DSHS a monthly detailed and accurate invoice describing the
services performed in completion of the responsibilities outlined in this Statement of
Work. Invoices and supporting documentation must be submitted to DSHS in
accordance with Table 1, Invoice Submission Schedule.
B. Grantee shall request payments monthly using the State of Texas Purchase Voucher
(Form B-13). Invoices and supporting documentation must be submitted monthly to
prevent delays in subsequent months. Grantees that do not incur expenses within a
month are required to submit a "zero dollar" invoice on a monthly basis. Grantee must
DSHS Contract No. HHS001315700012 Page 8 of 10
Attachment A-4
DocuSign Envelope ID: A25E5CEA-FMA-4EFF-691 E-AC517ABAFACD
submit a final close-out invoice. Invoices received more than thirty (30) days after
each fiscal year are subject to denial of payment. Invoices and all supporting
documentation must be submitted by mail, fax, or email.
1. If by mail, Grantee shall submit to:
Department of State Health Services
Claims Processing Unit, MC 1940
P.O. Box 149347
Austin, TX 78714-9347
2. If by fax, Grantee shall submit to (512) 458-7442.
3. If by email, Grantee shall submit to invoicesAdshs.texas.gov and
CMSinvoices@dshs.texas.gov.
Failure to submit required information may result in delay of payment or return of
invoice. Billing invoices must be legible. Illegible or incomplete invoices which
cannot be verified will be disallowed for payment.
Table 1: Invoice Submission Schedule
Period Covered
Due Date
September 1 st through September
30th
October 31 st
October 1 st through October 31 st
November 30th
November 1 st through November
30th
December 31 st
December 1 st through December 31 st
January 31 st
January 1 st through January 31 st
February 28th (or February 29th in
leap year)
February 1 st through February 28th
or February 29th in leap year)
March 31 st
March 1 st through March 31 st
Aril 30th
April 1 st through April 30th
May 31 st
May 1 st through May 31 st
June 30th
June 1 st through June 30th
July 31 st
July 1 st through July 31 st
August 31 st
August 1 st through August 31 st
September 30th
Final Close-out Invoice
Due Date
August 1 st through August 31 st
September 30th
C. Grantee shall submit the Financial Status Report (FSR-269A) twice per fiscal year as
outlined in Table 2, FSR Submission Schedule. Grantee shall email the FSR-269A to
the following email addresses: FSRgrants@dshs.texas.gov and
CMSInvoices@dshs.texas.gov. Grantee shall submit the final financial status report
no later than thirty (30) days following the end of the Contract term.
DSHS Contract No. HHS001315700012 Page 9 of 10
Attachment A-4
DocuSign Envelope ID: A25E5CEA-FD9A-4EFF-B9IE-AC517ABAFACD
Table 2: FSR Submission Schedule
Period Covered
Due Date
September 1 st through February
28th or February 29th in leap year)
March 31 st
Final Financial Status Report
March 1 st through August 31 st
September 30th
D. Grantee will be paid on a cost reimbursement basis and in accordance with the budget
for the corresponding year under this Contract.
DSHS Contract No. HHS001315700012 Page 10 of 10
Attachment A-4
DocuSign Envelope ID: A25E5CEA-FD9A-4EFF-B91E-AC517ABAFACD
Categorical Budget
Budget Period
Personnel
Fringe Benefits
Travel
Equipment
Supplies
Contractual
Other
Total Direct
Charges
Indirect Charges
Total Charges
ATTACHMENT B-3
REVISED BUDGET
Epi
CARES Funding
August 17, 2020
to
July 31, 2026
$58,126.00
$26,157.00
$0.00
$0.00
$0.00
$70,625.00
$0.00
$154,908.00
$0.00
$154,908.00
Epi
Expansion
Funding
August 31, 2021
to
July 31, 2026
$130,250.00
$58,613.00
$0.00
$0.00
$66,676.00
$83,322.00
$0.00
$338,861.00
$0.00
$338,861.00
Contract Total
$188,376.00
$84,770.00
$0.00
$0.00
$66,676.00
$153,947.00
$0.00
$493,769.00
$0.00
$493,769.00
DSHS Contract No. HHS001315700012 Page 1 of 1
Attachment B-3